Effect of Adjuvant Capecitabine or Fluorouracil, with or without Oxaliplatin, on Survival Outcomes in Stage III Colon Cancer and the Effect of Oxaliplatin on Post-Relapse Survival: A Pooled Analysis of Individual Patient Data from Four Randomised Controlled Trials

BACKGROUND: Oxaliplatin-based adjuvant therapy is the standard of care for stage III colon cancer. Adjuvant capecitabine with or without oxaliplatin versus leucovorin and fluorouracil with or without oxaliplatin has not been directly compared; therefore, we aimed to analyse the efficacy and safety o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Oncol
Main Authors: Schmoll, Hans-Joachim, Twelves, Chris, Sun, Weijing, O'Connell, Michael J, Cartwright, Thomas, McKenna, Edward, Saif, Muhammad, Lee, Steve, Yothers, Greg, Haller, Daniel
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4435787/
https://ncbi.nlm.nih.gov/pubmed/25456367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(14)70486-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados